Patent ID: 7745430

Claim:
A transnasal anticonvulsive pharmaceutical composition comprising from about 4 to 6% by weight of diazepam as an active ingredient, from about 8 to 12% by weight of water, a fatty acid ester, from about 30 to 45% by weight of diethylene glycol monoethyl ether, from about 12 to 17% by weight of ethanol and from about 0.5 to 1.2% by weight of sodium glycocholate, wherein the weight of the fatty acid ester is at least 2-fold higher than that of water and is at least 2-fold higher than that of ethanol, the fatty acid ester is contained in an amount of from about 38 to 42% by weight, based on the total weight of the composition, and is a mixture of caprylocaproyl macrogol-8-glycerides and ethyl laurate in a weight ratio of from 4.5:3.5 to 5.5:2.5.